#United States #New York #Securities Fraud #Rosen Law Firm #Microvast Holdings

Investors in Microvast Holdings, Inc. Face a Critical Deadline for a Securities Fraud Lawsuit

Investors who purchased shares of Microvast Holdings, Inc. (NASDAQ: MVST) between April 1, 2025, and March 16, 2026, have the opportunity to join a crucial legal action against the company. The Rosen Law Firm, a prominent firm specializing in investor rights, has issued a reminder that September 21, 2026, is the deadline to apply as a lead plaintiff in this securities fraud lawsuit.

Important Details for Potential Plaintiffs

If you invested in Microvast during the aforementioned class period, you may be entitled to compensation without any out-of-pocket costs through a contingency fee model. This means that you won't have to pay legal fees unless the case is successful.

To join this class action, investors can visit Rosen Law Firm’s website or contact Phillip Kim, an attorney at the firm, toll-free at 866-767-3653, or via email at [email protected]. The firm is actively seeking to represent investors who have suffered due to the alleged misconduct by Microvast.

Why Choose Rosen Law Firm?

Rosen Law Firm emphasizes the importance of selecting a well-qualified legal counsel that possesses the necessary experience in securities class actions. Many firms known for sending out notifications often lack the capability and resources to litigate effectively. In contrast, Rosen Law Firm has a trail of successful settlements and is recognized as one of the top legal firms for handling securities-related cases. The firm has achieved remarkable outcomes for investors, including the largest securities class action settlement ever against a Chinese company. In 2019 alone, they recovered over $438 million for investors.

The Nature of the Allegations Against Microvast

The lawsuit against Microvast accuses the company of making false statements and failing to disclose critical information that misled investors. Specifically, it highlights three key issues:
1. Overstated Financial Position: Investors were misled about Microvast's ability to meet its profit margins due to inventory management problems and delays in commercial rollouts by its clients.
2. Misleading Expansion Claims: The company reportedly exaggerated its capability to complete the Huzhou Phase 3.2 expansion by 2025, creating unrealistic expectations among investors.
3. Material Misstatements: As a consequence of the aforementioned issues, all public statements made by the defendants were allegedly materially false and misleading, impacting investors adversely.

When the truth was revealed, many investors experienced significant losses, illustrating the adverse effects of the defendants' actions.T

Joining the Action

Investors are encouraged to act swiftly, as many legal avenues involve strict deadlines. Until the class is certified, investors remain unrepresented unless they choose to retain counsel. Nevertheless, participation in this case does not necessitate acting as a lead plaintiff, allowing investors to weigh their options carefully.

For regular updates on the case and additional information, potential plaintiffs can follow the Rosen Law Firm on platforms like LinkedIn and Twitter. With a proven track record, Rosen Law Firm stands ready to advocate for investors affected by securities fraud.

This pivotal class action represents not just an opportunity for personal restitution but is also part of a larger effort to uphold accountability among publicly traded companies, especially in sectors that impact economic markets substantially. Investors are urged to be proactive in their response to this situation and consider their legal options before the deadline passes.